AC018867.2 | | Predicted membrane proteins
| | | | | Group enriched |
AC019206.1 | Uncharacterized protein | | | | | | Group enriched |
ADD2 | Adducin 2 (beta) | Cytoskeleton related proteins
| | | | | Group enriched |
AICDA | Activation-induced cytidine deaminase | Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
ANKRD18A | Ankyrin repeat domain 18A | | | | | | Group enriched |
ANKRD61 | Ankyrin repeat domain 61 | | | | | | Group enriched |
AQP9 | Aquaporin 9 | Predicted membrane proteins
| | | | | Group enriched |
BAI1 | Brain-specific angiogenesis inhibitor 1 | Cancer-related genes G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
BLK | B lymphoid tyrosine kinase | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
BTLA | B and T lymphocyte associated | CD markers Predicted membrane proteins
| | | | | Group enriched |
C12orf77 | Chromosome 12 open reading frame 77 | | | | | | Group enriched |
C19orf59 | Chromosome 19 open reading frame 59 | Predicted membrane proteins
| | | | | Group enriched |
CA1 | Carbonic anhydrase I | Enzymes FDA approved drug targets Plasma proteins
| | | | | Group enriched |
CASP16 | Caspase 16, apoptosis-related cysteine peptidase (putative) | Enzymes
| | | | | Group enriched |
CASP5 | Caspase 5, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Plasma proteins
| | | | | Group enriched |
CCL7 | Chemokine (C-C motif) ligand 7 | Cancer-related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CCR7 | Chemokine (C-C motif) receptor 7 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CD19 | CD19 molecule | CD markers Disease related genes Predicted membrane proteins
| | | | | Group enriched |
CD72 | CD72 molecule | CD markers Predicted membrane proteins
| | | | | Group enriched |
CEACAM4 | Carcinoembryonic antigen-related cell adhesion molecule 4 | Predicted membrane proteins
| | | | | Group enriched |
CEACAM5 | Carcinoembryonic antigen-related cell adhesion molecule 5 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CEACAM6 | Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Group enriched |
CHIT1 | Chitinase 1 (chitotriosidase) | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
CHODL | Chondrolectin | Predicted membrane proteins
| | | | | Group enriched |
CHRDL2 | Chordin-like 2 | Predicted secreted proteins
| | | | | Group enriched |
CHST13 | Carbohydrate (chondroitin 4) sulfotransferase 13 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
CLEC17A | C-type lectin domain family 17, member A | Predicted membrane proteins
| | | | | Group enriched |
CLEC4D | C-type lectin domain family 4, member D | Predicted membrane proteins
| | | | | Group enriched |
CLEC4G | C-type lectin domain family 4, member G | Predicted membrane proteins
| | | | | Group enriched |
CLEC4M | C-type lectin domain family 4, member M | CD markers Predicted membrane proteins
| | | | | Group enriched |
CLEC5A | C-type lectin domain family 5, member A | Predicted membrane proteins
| | | | | Group enriched |
CNR2 | Cannabinoid receptor 2 (macrophage) | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CR2 | Complement component (3d/Epstein Barr virus) receptor 2 | CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
CXCL13 | Chemokine (C-X-C motif) ligand 13 | Cancer-related genes Predicted secreted proteins
| | | | | Group enriched |
CXCL9 | Chemokine (C-X-C motif) ligand 9 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
CXCR5 | Chemokine (C-X-C motif) receptor 5 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CXXC11 | CXXC finger protein 11 | Predicted membrane proteins
| | | | | Group enriched |
DNAH10 | Dynein, axonemal, heavy chain 10 | | | | | | Group enriched |
DRD5 | Dopamine receptor D5 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
FAM129C | Family with sequence similarity 129, member C | | | | | | Group enriched |
FAM159A | Family with sequence similarity 159, member A | Predicted membrane proteins
| | | | | Group enriched |
FAM178B | Family with sequence similarity 178, member B | | | | | | Group enriched |
FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Group enriched |
FCN1 | Ficolin (collagen/fibrinogen domain containing) 1 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
FCRL2 | Fc receptor-like 2 | CD markers Predicted membrane proteins
| | | | | Group enriched |
FCRL3 | Fc receptor-like 3 | CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
FCRL4 | Fc receptor-like 4 | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | | | Group enriched |
FCRLA | Fc receptor-like A | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
GDPD2 | Glycerophosphodiester phosphodiesterase domain containing 2 | Cytoskeleton related proteins Enzymes Predicted membrane proteins
| | | | | Group enriched |
GPR88 | G protein-coupled receptor 88 | G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |